Skip to main content
Sigachi Industries Limited logo

Sigachi Industries Limited — Investor Relations & Filings

Ticker · SIGACHI ISIN · INE0D0K01022 LEI · 335800UMZILSBLDXKT94 BSE.NS Manufacturing
Filings indexed 433 across all filing types
Latest filing 2025-02-04 Regulatory Filings
Country IN India
Listing BSE.NS SIGACHI

About Sigachi Industries Limited

https://sigachi.com/

Sigachi Industries Limited is a global manufacturer specializing in Microcrystalline Cellulose (MCC) and cellulose-based excipients. The company produces a comprehensive range of MCC grades tailored for the pharmaceutical, food, nutraceutical, and cosmetic sectors, supporting applications such as direct compression, wet granulation, and stabilization. Its product portfolio includes specialized excipients and pre-formulated blends designed to enhance drug delivery and product consistency. Operating with a focus on research and development, the company maintains high-quality standards through advanced manufacturing processes and international certifications. Sigachi provides functional ingredients that serve as binders, disintegrants, and carriers, catering to a diverse international clientele with customized solutions for complex formulation challenges.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated February 4, 2025, announcing the establishment of a new R&D center by Sigachi Industries Limited. It details the company's strategic investment in research and development, the purpose of the new facility, and includes forward-looking statements. There are no financial statements, regulatory filings, voting results, or management changes reported. The document is an announcement of a corporate development rather than a financial report or regulatory filing. It is not a report publication announcement since it does not mention the release or availability of a report. Therefore, the document best fits the category of a general regulatory announcement or miscellaneous corporate update, which falls under Regulatory Filings (RNS).
2025-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Q3 FY 2024-25 results of Sigachi Industries Limited. It includes management commentary on financial performance, operational highlights, future outlook, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings call, and it contains detailed financial figures and management discussion. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or summary. Therefore, the correct classification is CT with high confidence.
2025-01-23 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Sigachi Industries Limited, dated January 22, 2025. It includes information about the appointment of an Independent Director, voting instructions, regulatory references to SEBI Listing Obligations and Disclosure Requirements Regulations, and procedural details for remote e-voting. The document is not a report of voting results but a notice seeking shareholder consent via postal ballot. It is not an annual report, earnings release, or management report. It is also not a proxy solicitation or voting results declaration but a notice for voting. Therefore, the document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2025-01-22 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter ended 31.12.2024. It mentions that the results were approved in a board meeting and published in newspapers. The document includes clippings of the newspaper publications. The key phrase is 'Unaudited Financial Results for quarter ended 31.12.2024' which indicates this is a quarterly financial results announcement. The document is a notification or intimation about the publication of these results rather than the full financial report itself. Given the length (15,000 characters) and the content, it is not a full interim or quarterly report but rather an announcement of the results publication. However, since it contains the actual financial results (unaudited) for the quarter, it qualifies as an Interim / Quarterly Report (IR). The document is not merely a short announcement or a certification but includes substantive financial data for the quarter. Therefore, the correct classification is Interim / Quarterly Report (IR). Q3 2025
2025-01-20 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a "Statement of Deviation / Variation in utilization of funds raised in IPO / Conversion of Share Warrants into Equity Shares" for the quarter ended December 31, 2024. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 32(1), which mandates disclosure of deviations or variations in fund utilization. The document includes a statement of deviation/variation and mentions a monitoring agency report being separately filed. The content is a regulatory compliance disclosure about fund utilization deviations related to IPO and share warrant conversions, not a full financial report or earnings release. The document length is 4130 characters, relatively short, and it serves as an official regulatory announcement to exchanges. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-01-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges announcing the availability of the audio recording of the Q3 FY 2024-25 earnings call on the company's website. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure requirements. The document does not contain the transcript or financial data itself but only informs about the availability of the audio recording. Given the short length (1155 characters) and the nature of the content (announcement of availability of earnings call audio), this is not the earnings release or call transcript itself but an announcement related to the earnings call. According to the classification rules, such announcements are best classified as Regulatory Filings (RNS) because it is a general regulatory announcement and does not contain the full transcript or financial data.
2025-01-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.